share_log

通化东宝(600867.SH):预混型门冬胰岛素新增准入约5000家医院

Tonghua Dongbao Pharmaceutical (600867.SH): The newly approved pre-mixed insulin has been added to about 5000 hospitals.

Gelonghui Finance ·  Jul 25 04:22

On July 25th, Golonghui reported that Tonghua Dongbao (600867.SH) stated on the interactive platform that in the continuation of the centralized procurement bidding, the company acquired more than 30% of the national secondary distribution, about 10 million units. At the same time, there has been a significant improvement and breakthrough in the hospital access of insulin analogs, including about 1,400 newly admitted hospitals for glycine insulin and about 3,000 newly admitted hospitals for Menodan insulin. Additionally, about 5,000 newly admitted hospitals for premixed Menodan insulin. Furthermore, the company will continue to increase investment in grassroots markets, retail channels, private hospitals, and other non-standard markets to expand the incremental space.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment